Treatment approaches in Gilles de la Tourette syndrome.


The neurological disorder Gilles de la Tourette syndrome is most often treated with the receptor blocker haloperidol, which also produces multiple side-effects, including the risk for tardive dyskinesia. In placebo control double-blind studies, two other neuroleptic drugs, fluphenazine and trifluoperazine, were found to be as efficaceous as haloperidol, but… (More)


Cite this paper

@article{Borison1983TreatmentAI, title={Treatment approaches in Gilles de la Tourette syndrome.}, author={Richard L. Borison and L. K. Ang and William J. Hamilton and Bob Diamond and J. M. Davis}, journal={Brain research bulletin}, year={1983}, volume={11 2}, pages={205-8} }